The effect of mucolytic agents on gene transfer across a CF sputum barrier in vitro

Gene Therapy

Volumn 5, Issue 1, 1998, Pages 91-98

  Stern, M ^a   Caplen, N J ^a   Browning, J E ^a   Griesenbach, U ^a   Sorgi, F ^b   Huang, L ^b   Gruenert, D C ^c   Marriot, C ^d   Crystal, R G ^e   Geddes, D M ^a   Alton, E W F W ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Cystic fibrosis; Gene therapy; rhDNase; Sputum

Indexed keywords

ACETYLCYSTEINE; BETA GALACTOSIDASE; DEOXYRIBONUCLEASE; DNA; DORNASE ALFA; LIPOSOME; LYASE; LYSINE; MUCOLYTIC AGENT; NACYSTELYN; UNCLASSIFIED DRUG;

ADENOVIRUS; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DNA TRANSFECTION; GENE TRANSFER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REPORTER GENE; SPUTUM;

ADENOVIRIDAE;

EID: 6844266288     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300556     Document Type: Article

References (39)

1. Rommens JM et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989, 245: 1059-1065.
2. Riordan JR et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245: 1066-1073.
3. Kerem B et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989; 245: 1073-1080.
4. Zabner J et al. Adenovirus-mediated gene transfer transiently corrects the chloride defect in nasal epithelia of patients with cystic fibrosis. Cell 1993; 75: 1-20.
5. Crystal RG et al. Administration of an adenovirus containing human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat Genet 1994; 8: 42-51.
6. Caplen NJ et al. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nature Med 1995; 1: 39-46.
7. Knowles MR et al. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. New Engl J Med 1995; 333: 823-831.
8. Shak S et al. Recombinant human DNase 1 reduces the viscosity of cystic fibrosis sputum. Proc Natl Acad Sci USA 1990; 87: 9188-9192.
9. Hodson ME. Aerosolized dornase alpha (rhDNase) for therapy of cystic fibrosis Am J Respir Crit Care Med 1995; 151: S70-S74.
10. MacGreggor GR, Caskey CT. Construction of plasmids that express E. Coli β-galactosidase in mammalian cells. Nucleic Acids Res 1989; 17: 2365-2369.
11. Gao X, Huang L. A novel cationic lipid reagent for efficient transfection of mammalian cells. Biochem Biophys Res Comm 1991; 179: 280-285.
12. Hersh J, Crystal RG, Bewig B. Modulation of gene expression after replication deficient recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector. Gene Therapy 1995; 2: 124-131.
13. Clamp JR. The properties of the mucus gel layer in the gastrointestinal tract. In: Brostoff J. Challacombe SJ (eds). Food Allergy and Intolerance. WB Saunders: London, 1987, pp 190-205.
14. Thomton DJ, Sheehan JK, Lindgren H, Carstedt I. Mucus glycoproteins from cystic fibrosis sputum. Macromolecular properties and structural 'architecture'. Biochem J 1991; 276: 667-675
15. - current status of the host-bacterium interaction. J Infect Dis 1985; 151: 575-580.
16. Govan JRW, Harris GS. Pseudomonas aeruginosa and cystic fibrosis: unusual bacterial adaptation and pathogenesis. Microbiol Sci 1986; 3: 302-308.
17. Marriot C, Ingham S, Pritchard K, Williams M. The effect of Nacystelyn on the viscoelastic properties of mucus and frog palate transport rate. Eur Resp J 1991; 4: 378s.
18. Laharrague PF et al. In vitro effect of the slime of Pseudomonas aeruginosa on the function of human polymorphonuclear neutrophils. Infect Immunol 1984; 44: 760-762.
19. Oliver AM, Weir DM. The effect of Pseudomonas alginate on rat alveolar macrophage phagocytosis and bacterial opsonisation. Clin Exp Immunol 1985; 59: 190-196.
20. Mai GT, Seow WK, McCormack JG, Thong YH. In vitro immunosuppressive properties of the exopolysaccharide of mucoid strains of Pseudomonas aeruginosa. Int Arch Allergy Appl Immunol 1990; 92: 105-112.
21. Ramphal R, Pier GB. Role of Pseudomonas aeruginosa mucoid exopolysaccharide in the adherence to tracheal cells. Infect Immunol 1985; 47: 1-4.
22. Marcus H, Baker NR. Quantitation of adherence of and non-mucoid Pseudomonas aeruginosa to hamster tracheal cells. Infect Immunol 1985; 47: 723-729.
23. Doig P, Smith NR, Todd T, Irvin RT. Characterization of the binding of Pseudomonas aeruginosa alginate to human epithelial cells. Infect Immunol 1987; 55: 1517-1522.
24. Gacesa P. Enzymic degradation of alginates. Int J Biochem 1992; 24: 545-552.
25. Mai GT et al. Inhibition of adherence of mucoid Pseudomonas aeruginosa by alginase, specific monoclonal antibodies, and antibiotics. Infect Immunol 1993; 61: 4338-4343.
26. Mrsny RJ et al. Addition of a bacterial alginate lyase to purulent CF sputum in vitro can result in the disruption of alginate and modification of sputum viscoelasticity. Pulin Pharmacol 1994; 7: 357-366.
27. Potter JL, Matthews LW, Lemm J, Spector JS. Composition of pulmonary secretions from patients with and without cystic fibrosis. Am J Dis Child 1960; 199: 493-495.
28. Matthews LW, Spector S, Lemm J, Potter JL. Studies on pulmonary secretions. Am Rev Respir Dis 1963; 88: 188-204.
29. Brandt T, Breitenstein S, van der Hardt H, Tummler B. DNA concentration and length in sputum of patients with cystic fibrosis during inhalation with recombinant human DNase. Thorax 1995; 50: 880-882
30. Sternberg B, Sorgi F, Huang L New structures in complex formation between DNA and cationic liposomes visualised by freeze-fracture electron microscopy. FEBS Lett 1994; 336: 361-366.
31. Gluzman Y. SV-40 transformed simian cells support the replication of early SV40 mutants. Cell 1981; 23: 175-182.
32. Cozens AL et al. CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Biol 1994; 10: 38-17.
33. Cozens AL et al. Characterisation of immortal cystic fibrosis tracheobronchial gland epithelial cells. Proc Natl Acad Sci USA 1992; 89: 5171-5175.
34. Caplen NJ et al. Gene therapy for cystic fibrosis in humans by liposome-mediated DNA transfer: the production of resources and the regulatory process Gene Therapy 1994; 2: 1-9.
35. Felgner JH et al. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem 1994; 269: 2530-2561.
36. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
37. Sandberg JW et al. Improving access to intestinal stem cells as a step toward intestinal gene transfer. Hum Gene Ther 1994; 5: 323-329.
38. Widdicombe J, Davies A. Respiratory Physiology. Edward Arnold: London, 1983, p 4.
39. Stewart MJ et al. Gene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in mice. Hum Gene Ther 1992; 3: 267-275.